IDEAYA Biosciences
Peter Teriete is a seasoned professional in the field of biochemistry and drug discovery, currently serving as Vice President and Senior Director of Lead Discovery at IDEAYA Biosciences since December 2020. With a strong commitment to cancer research through their role as Scientific Co-Founder at TumorGen, Inc., Peter's work addresses the critical challenges of metastasis, responsible for a high percentage of cancer fatalities. Additionally, Peter has held various positions at the Sanford Burnham Prebys Medical Discovery Institute, focusing on drug discovery and structure-based design across multiple diseases. An educator, Peter is the President of the German Pacific School San Diego, promoting cultural and language immersion. Peter holds a D.Phil in Biochemistry, Biophysics, and Molecular Biology from the University of Oxford and a BSc (Hons) in Biochemistry from the University of Leeds.
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California